Drug recall attorneys at Pintas & Mullins Law Firm announce that a CVS pharmacist recently found one 120-pill bottle of baby aspirin to contain acetaminophen pills instead. Advance Pharmaceuticals subsequently recalled nearly 16,500 bottles of baby aspirin pills. Acetaminophen is a pain reliever and fever reducer, similar to the active ingredient in Aspirin, acetylsalicylic acid. Brands …
Supreme Court Rules to Penalize Consumers Injured by Generic Drugs
Defective drug lawyers at Pintas & Mullins Law Firm have written extensively on the case of Mutual Pharmaceutical v. Bartlett, a case about the horrific injuries suffered by a New Hampshire woman, Karen Bartlett, after taking a generic painkiller. A federal jury awarded Bartlett $21 million when she sued Mutual Pharmaceutical for selling a defectively designed drug, a decision …
Supreme Court Bars Class-Action Claim against Major Corporation
Attorneys at Pintas & Mullins Law Firm report on a broad decision Thursday by the Supreme Court, which blocked a group of merchants from joining together in a class-action claim against American Express, forcing them to arbitrate their claims on an individual basis. This decision has a significant impact on consumer rights, because many consumers cannot …
FDA Investigates Zyprexa Patient Deaths
Dangerous drug lawyers at Pintas & Mullins Law Firm highlight a recent investigation initiated by the FDA concerning the death of two patients injected with the schizophrenia drug Zyprexa Relprevv. The patients died three to four days after receiving appropriate doses of the treatment. Zyprexa Relprevv is manufactured by Eli Lilly, to which it brought profits …
Study Finds Increased Musculoskeletal Problems in Statin Users
Dangerous drug lawyers at Pintas & Mullins Law Firm report of a recent study published in JAMA Internal Medicine suggesting that people who take statins are more likely to develop musculoskeletal problems. Statins are a class of cholesterol-lowering drugs that inhibit enzymes that are central to the production of cholesterol in the liver. Well-known drugs such as …
FDA Panel to Consider the Future of Avandia, other Diabetes Treatments
Avandia lawyers at Pintas & Mullins Law Firm affirm that June 7, 2013 marked the start of an FDA advisory committee meeting to reconsider the safety and use of Avandia. Three years ago the agency voted to sharply curtail the diabetes drugs’ use. A former blockbuster, Avandia was once the top-selling diabetes pill in the world. …
Anti-Seizure Drug Potiga Manufacturer Blue It
Dangerous drug lawyers at Pintas & Mullins Law Firm affirm that the FDA recently warned the public that Potiga (generic Ezogabine), an anti-seizure medication, can cause blue skin and eye discolorations. The agency does not yet know if these abnormalities are reversible. It seems that the manufacturer, GlaxoSmithKline, indeed blue this one, as nearly 3,000 people …
Hospira Received Four FDA Warning Letters in 2012-2013
Drug recall lawyers at Pintas & Mullins Law Firm report that Hospira Inc. is again under fire from the FDA over, among many things, unsanitary conditions at its pharmaceutical manufacturing plant in India. This most recent federal warning is just the latest in a slew of negative letters and inspection reports. Between June 2012 and June …
ER Visits Linked to Sleeping Pills up 220% Since 2005
Ambien lawyers at Pintas & Mullins Law Firm recently reported that the FDA and other drug agencies recently lowered the recommended dosages for women taking sleeping pills. Our attorneys would also like to highlight that ER visits associated with these sleeping pills have risen substantially – by nearly 220% – in recent years. With drug overdose …
Dietary Supplements Account for Over Half FDA Class I Recalls
Drug recall lawyers at Pintas & Mullins Law Firm highlight a recent study which found that, between 2004 and 2012, dietary supplements made up more than half of all FDA Class I drug recalls. “Class I” refers to recalls of drugs that have a reasonable probability of causing serious health consequences or death. The study was …
More Sterile Compounded Products Recalled
Drug recall lawyers at Pintas & Mullins Law Firm report of yet another compounding pharmacy recall, this one initiated by The Compounding Shop of St. Petersburg, Florida. The recall was triggered by problems uncovered during FDA health inspections. The Compounding Shop is currently in the midst of alerting its customers of the recall while the FDA is …
Reglan, Tecfidera Carry Serious, Life-Altering Side Effects
Dangerous drug lawyers at Pintas & Mullins Law Firm warn patients taking the acid reflux and heartburn drug Reglan that it has been linked to serious, permanent, and fatal side effects. Similarly, patients taking multiple sclerosis medication Tecfidera may be at risk of developing a fatal brain disease. Reglan, which is the brand name for generic …
U.S. Colleges Attempt to Regulate A.D.H.D Prescriptions
Dangerous drug lawyers at Pintas & Mullins Law Firm report that dozens of colleges throughout the country are tightening the rules on A.D.H.D. diagnoses and treatments in effort to curb illegal use of the drugs. Some are re-considering whether or not their student health offices should handle A.D.H.D. treatments at all. The use and abuse of …
Crestor Manufacturer Struggles in Face of Litigation, Patent Loss
Crestor lawyers at Pintas & Mullins Law Firm affirm that the drug’s manufacturer, AstraZeneca, is reporting profit drops of more than 35% due to loss of exclusivity and litigation surrounding its top-seller, Crestor. The popular statin drug is associated with an increased risk of liver and kidney injury, along with other life-threatening health effects. Crestor, along …
Two More Compounding Pharmacies Issue Recall
Drug recall lawyers at Pintas & Mullins Law Firm report of two additional compounding pharmacies that recently issued major recalls. The first was Florida-based Balanced Solutions Compounding Pharmacy and involves all lots of its sterile drug products. The second was an Indianapolis compounding pharmacy, Nora Apothecary Alternative Therapies. Nora Apothecary is recalling nearly 100 of its …
Yet Another Compounding Pharmacy Issues Recall
Green Valley Drugs, of Henderson, Nevada, is voluntarily recalling all lots of its sterile products. Drug recall lawyers at Pintas & Mullins Law Firm announce that this is the fifth recall since the outbreak of fungal meningitis from the New England Compounding Center (NECC) killed 51 people and sickened 700 more. Since the fatal NECC outbreak in …
Stevens-Johnson Syndrome from Sulfa-Based Antibiotics
SJS and TENS lawyers at Pintas & Mullins Law Firm report of the latest class of drugs that may induce Stevens – Johnson syndrome (SJS): sulfa-based antibiotics. Recently, a 34-year-old man sought treatment for an upper respiratory tract infection and he was prescribed ciprofloxacin, which ultimately caused his SJS. The patient went to his family physician …
Oklahoma Dentist Patients urged to test for HIV and Hepatitis Exposure
Malpractice lawyers at Pintas & Mullins Law Firm report of a troubling story out of Tulsa, Oklahoma that will force about 7,000 patients to be tested for possible HIV and hepatitis infection from a suburban dentist office. The Oklahoma State Department of Health will offer free testing to those patients in the upcoming months. All patients …
FDA Says it Cannot Control Compounding Pharmacies
The flurry of federal and state investigations into compounding pharmacies is leading to a consequent wave of drug recalls and reports of contaminations, and the FDA is saying that it can’t keep up. Contaminated drug lawyers, along with consumer advocates and healthcare professionals, refute that the agency can, and should, keep pace with facility inspection demands. According …
Another Compounding Pharmacy, Pallimed, Announces Recall
Contaminated drug lawyers at Pintas & Mullins Law Firm announce yet another recall initiated by a compounding pharmacy, this time Pallimed Solutions of Woburn, Massachusetts. The company is recalling all sterile compound products distributed since January 1, 2013. The recalled products from this pharmacy were distributed to patients and healthcare facilities in 21 states, including California, …
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- Next Page »